Concepedia

Camillo Porta

CP

296

Publications

48.6K

Citations

70

H-Index

1992

Active since

Affiliations

University of Pavia(Current)

Istituti di Ricovero e Cura a Carattere Scientifico

Institut Gustave Roussy

University of Bari Aldo Moro

Memorial Sloan Kettering Cancer Center

Camillo Porta is an author at University of Pavia specializing in medicine, oncology, and urology.

Top concepts

MedicineOncologyUrologyCancer TherapyRadiation OncologyCancer ResearchPharmacologyPharmacotherapyMolecular OncologyHealth

Publications per year

1992–2025

296

Publications

296

Sorafenib in Advanced Hepatocellular Carcinoma

Josep M. Llovet, Sergio Ricci, Vincenzo Mazzaferro et al. · New England Journal of Medicine · 2008 · 12.8K citations · Full text

Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma

Robert J. Motzer, Nizar M. Tannir, Osvaldo Arén Frontera et al. · New England Journal of Medicine · 2018 · 4.5K citations · Full text

Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial

Robert J. Motzer, Bernard Escudier, Stéphane Oudard et al. · The Lancet · 2008 · 3K citations

Urology, Surgical Oncology, Genitourinary Cancer +5

Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Bernard Escudier, Camillo Porta, Manuela Schmidinger et al. · Annals of Oncology · 2014 · 2.3K citations · Full text

Urology, Genitourinary Cancer, Medicine +5

Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma

Robert J. Motzer, B. Yа. Alekseev, Sun Young Rha et al. · New England Journal of Medicine · 2021 · 1.7K citations · Full text

Rows per page

1–5 of 296